v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04344041 |
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
cedric.annweiler@chu-angers.fr |
Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2020-04-14 |
Recruitment status
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
Completed |
Study design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Open label |
Center
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
multi-center |
Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
inclusion criteria: - age ≥ 65 years old - infection with covid-19 diagnosed with rt-pcr sars-cov-2 or withct-scan of the chest suggesting viral pneumonia of peripheral predominance in a clinically relevant context - patient seen in hospitalization or consultation or in nursing home - diagnosed within the preceding 3 days - having at least one of the following two risk factors for complications: - age ≥75 years - peripheral capillary oxygen saturation (spo2) ≤ 94% ambient air, or a partial oxygen pressure (pao2) to fraction of inspired oxygen (fio2) ratio ≤ 300 mmhg - patients affiliated with or benefitting from a social security scheme - written and signed consent of the patient or a relative or legal representative or, if not possible, emergency inclusion procedure |
Exclusion criteria
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
- organ failure requiring admission to a resuscitation or high dependency unit - comorbidity that is life-threatening in the short-term (life expectancy <3 months) - any reason that makes follow-up at day 28 impossible - vitamin d supplementation in the previous month, with the exception of treatment providing less than 800 iu of vitamin d per day - contraindication for vitamin d supplementation: active granulomatosis (sarcoidosis, tuberculosis, lymphoma), history of calcic lithiasis, known hypervitaminosis d or hypercalcemia, known intolerance to vitamin d - participation in another simultaneous trial - safeguard of justice - peripheral capillary oxygen saturation (spo2) ≤92% in spite of an oxygen therapy > 5l/min |
Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
University Hospital, Angers |
Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
65 |
Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Countries
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
France |
Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Moderate/severe disease at enrollment |
Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
4: Moderate/severe disease at enrollment |
Total sample size
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
260 |
primary outcome
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Number of death of any cause, during the 14 days following the inclusion and intervention. |
Notes
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Feb. 25, 2021, 7:58 p.m. Source : ClinicalTrials.gov |
Phase 3 |
Arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 1370, "treatment_name": "Vitamin d", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1370, "treatment_name": "Vitamin d", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}] |